Chronic Lymphocytic Leukaemia
Showing 1 - 25 of >10,000
Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance
Not yet recruiting
- Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
- (no location specified)
Dec 16, 2022
Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom
Recruiting
- Chronic Lymphocytic Leukemia, CLL
-
Aylesbury, United Kingdom
- +7 more
Jan 12, 2023
Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)
Active, not recruiting
- Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
- Acalabrutinib capsule
-
Ahmedabad, India
- +12 more
Feb 2, 2023
Retention Rate of Acalabrutinib in a Non-interventional Setting
Recruiting
- Chronic Lymphocytic Leukaemia (CLL)
-
Zittau, GermanyResearch Site
Jan 12, 2023
Pneumococcal Vaccination in Chronic Lymphocytic Leukaemia
Recruiting
- Pneumococcal Infections
- +3 more
- Prevnar13
-
Amsterdam-Zuidoost, NetherlandsAmsterdam UMC Locatie AMC
Dec 3, 2021
Chronic Lymphocytic Leukemia, Minimal Residual Disease Trial in Bath (Exercise trial)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- Minimal Residual Disease
- Exercise trial
-
Bath, Bath & Northeast Somerset, United Kingdom
- +1 more
Oct 20, 2021
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in London (NVG-111, NVG-111 (RP2D))
Recruiting
- Chronic Lymphocytic Leukaemia
- +2 more
- NVG-111
- NVG-111 (RP2D)
-
London, United KingdomUniversity College London Hospital
Jun 22, 2021
Chronic Lymphocytic Leukemia Stage A(0), Chronic Lymphocytic Leukemia Stage A(I), Chronic Lymphocytic Leukemia Stage A(II) Trial
Recruiting
- Chronic Lymphocytic Leukemia Stage A(0)
- +3 more
- Low Dose Selenious Yeast Tablets
- High Dose Selenious Yeast Tablets
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Nov 26, 2021
Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- CC312
-
Tianjin, Tianjin, ChinaInstituteHBDH
Sep 12, 2023
Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax
Recruiting
- Chronic Lymphocytic Leukemia
-
London, London, City Of, United Kingdom
- +9 more
Jan 13, 2023
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical
Active, not recruiting
- Hodgkin's Lymphoma
- +8 more
- Reduced intensity haplodentical stem cell transplant
- Myeloablative haploidentical stem cell transplant
-
Birmingham, United Kingdom
- +11 more
Sep 27, 2021
Non Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia Trial in France, United Kingdom (Tirabrutinib)
Completed
- Non Hodgkins Lymphoma
- Chronic Lymphocytic Leukaemia
-
Lille, France
- +5 more
Feb 22, 2021
B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose
Completed
- B-cell Lymphoma
- +2 more
- BI-1206 single agent dose escalation phase
- +3 more
-
Leicester, England, United Kingdom
- +4 more
Jun 17, 2021
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Belgium, France, Germany (BI 836826)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- BI 836826
-
Bruxelles, Belgium
- +9 more
Aug 10, 2020
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
-
Alessandria, Italy
- +17 more
Jan 3, 2022
Chronic Lymphoid Leukaemia Observatory in Finistere Area, France
Recruiting
- Chronic Lymphoid Leukaemia
-
Brest, FranceCHRU de Brest
Jan 27, 2021
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance
Active, not recruiting
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
-
Aichi, Japan
- +48 more
Dec 7, 2022
Outcomes in Chronic Myeloid Leukaemia
Completed
- Chronic Myeloid Leukaemia
-
York, United KingdomHaematological Malignancy Research Network
Jun 7, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Nemtabrutinib
- +2 more
- (no location specified)
Nov 22, 2023
Chronic Lymphocytic Leukemia Patients
Not yet recruiting
- Chronic Lymphocytic Leukemia
-
San Francisco, CaliforniaPower Life Sciences
Jun 2, 2023
Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Loncastuximab Tesirine
- (no location specified)
Jul 24, 2023
Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- (no location specified)
Jul 10, 2023
Biomarker for Infection Risk in CLL and MM
Not yet recruiting
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Screening
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
May 3, 2023
Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer
Completed
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Myeloma Coach or CLL Coach Mobile App
- Springboard Beyond Cancer informational website
-
Durham, North CarolinaDuke University
Jun 23, 2023
Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small
Recruiting
- Relapsed or Refractory CD19+ B-cell Lymphoma
- +2 more
- TBI-2001
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 26, 2023